Research Document: WHITE PAPER ON ENHANCING LOCAL PRODUCTION OF MEDICINES AND VACCINES IN NIGERIA

Posted Thu, Jun 30, 2022 10:15 AM

This white paper examines the feasibility of domestic manufacturing of medicines and vaccines in Nigeria, summarising major constraints and enablers with some key recommendations for the government and stakeholders which will push Nigeria closer towards pharmaceutical self-sufficiency.

The COVID-19 pandemic brought growing consensus that for a developing nation like Nigeria, with approximately 70% of locally consumed medicines and vaccines imported into the country, to reach pharmaceutical self-sufficiency, domestic production is imperative. The Nigerian Economic Summit Group (NESG), as a dialogue partner with a keen interest in the health sector, convened a panel of experts at the 27th Nigerian Economic Pre-Summit event, held on the 29th of September 2021, on Enhancing Local Production of Medicines and Vaccines in Nigeria to closely examine the pharmaceutical industry in Nigeria with the aim of discussing key bottlenecks to local manufacturing and the support required from the government, development partners, and other stakeholders; setting goals for local pharmaceutical production—short term and long term; and articulating an action plan to guide agenda setting for domestic manufacturing of medicines and vaccines.